A comprehensive view of Biopharmaceuticals/Biologics. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

MD Anderson Cancer Center, Obsidian Therapeutics get FDA approval to test metastatic melanoma treatment on humans that uses modified T-cells that produce interleukin; T-cells are activated by oral drug Acetazolamide

Biopharmaceutical firm Kamada swings to Q2 net loss of US$3.9M from US$0.9M net income a year ago, with total revenues down 3% year-over-year to US$23.6M; results driven by strong sales from firm’s four recently acquired FDA-approved commercial products

Fitch affirms Amgen's issuer default rating at BBB+ with stable rating outlook, says ChemoCentryx acquisition makes strategic sense, as it adds to Amgen's current presence in autoimmune diseases, inflammatory disorders and cancer

Merck collaborating with biotechnology firm Orna Therapeutics to develop, commercialize infectious disease, oncology vaccines and therapeutics based on Orna’s oRNA technology; Merck paid Orna US$150.0M upfront as part of deal

Merck signs agreement with Starpharma to test, characterize DEP dendrimer conjugates designed, synthesized by Starpharma; agreement expected to help Merck build its antibody drug conjugate capabilities

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count